For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. | After netting a $361 million series C funding round in October, ...

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid limited options. The FDA has granted orphan drug designation (ODD) to ARB1002, ...

This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...